# Elevated body roundness index and epilepsy prevalence: a cross-sectional study

**Authors:** Tieshi Zhu, Zhiwei Long, Saihui Zhu, Hui Mai

PMC · DOI: 10.1038/s41598-026-36062-8 · 2026-01-19

## TL;DR

This study finds that higher abdominal fat, measured by the Body Roundness Index, is linked to increased epilepsy prevalence in adults.

## Contribution

This is the first study to investigate the association between the Body Roundness Index and epilepsy prevalence.

## Key findings

- Higher Body Roundness Index was associated with increased odds of prevalent epilepsy in fully adjusted models.
- Participants in the highest tertile of BRI had significantly higher odds of epilepsy compared to the lowest tertile.
- Excluding participants on specific epilepsy medications did not change the results.

## Abstract

Obesity and epilepsy have a complex bidirectional relationship. Body mass index is commonly used to study this association but does not capture fat distribution. The Body Roundness Index (BRI) reflects abdominal adiposity. To our knowledge, the association between BRI and epilepsy prevalence has not been reported. We analyzed 17,914 adults from NHANES 2013–March 2020. BRI was modeled continuously and by tertiles. We used logistic regression to estimate odds ratios (ORs) and 95% CIs for prevalent epilepsy. Restricted cubic spline analyses evaluated nonlinearity. Prespecified sensitivity analyses excluded participants taking valproate (n = 6) or carbamazepine (n = 23). Variance inflation factors assessed multicollinearity. No nonlinear relationship between BRI and epilepsy (P = 0.609). Higher BRI was associated with greater odds of prevalent epilepsy in fully adjusted models (per-unit OR, 1.08; 95% CI 1.01–1.15; P = 0.03). Compared with Q1, Q3 showed higher odds (OR, 1.73; 95% CI 1.06–2.89; P = 0.03), whereas Q2 did not reach significance (OR, 1.58; 95% CI 0.97–2.63; P = 0.07). Findings were materially unchanged after excluding valproate or carbamazepine users. Subgroup point estimates exceeded 1 across strata; tests for interaction were not significant. Higher BRI is associated with higher prevalence of epilepsy. These results underscore the potential importance of abdominal fat distribution in epilepsy and warrant confirmation in larger prospective studies.

The online version contains supplementary material available at 10.1038/s41598-026-36062-8.

## Linked entities

- **Diseases:** epilepsy (MONDO:0005027)

## Full-text entities

- **Diseases:** abdominal adiposity (MESH:D000007), Obesity (MESH:D009765), epilepsy (MESH:D004827)
- **Chemicals:** valproate (MESH:D014635), carbamazepine (MESH:D002220)

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12891725/full.md

---
Source: https://tomesphere.com/paper/PMC12891725